Ege University
Izmir, Bornova, 3100, Turkey (Türkiye)
NCT Number: NCT06943963
The goal of this clinical trial was to evaluate whether a cognitive behavioral therapy (CBT) program focused on self-stigma could help reduce both self-stigma and gambling disorder severity in adults diagnosed with gambling disorder.
The main questions it aimed to answer were:
Did self-stigma-focused CBT lower self-stigmatizing thoughts in individuals with gambling disorder? Did the severity of gambling disorder symptoms decrease after the intervention? Did these changes remain stable after the treatment ended? Did self-stigma play a role in how the treatment worked? Participants were assigned to either an intervention group or a control group. Completed assessments before the treatment, after the treatment, and during the 1 month follow-up period.
Participants in the intervention group:
Received four sessions of cognitive behavioral therapy (face-to-face or online) targeting self-stigmatizing thoughts related to gambling Researchers compared the intervention and control groups to observe whether self-stigmatization affected treatment outcomes. Surveys used in this study included a self-stigma scale and the South Oaks Gambling Screen (SOGS).
A total of 26 participants (13 in each group) were enrolled in the study; in addition, 3 extra participants per group were included to account for possible dropouts.
The results were analyzed using statistical methods.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Izmir, Bornova, 3100, Turkey (Türkiye)
The total duration of the study is 13 months, from March 2024 to April 2025. The stages of the study were planned according to weeks (W). The timeline and phases of the study are as follows:
<!-- -->
The steps of the assessment session (clinical evaluation) are as follows:
Intervention Plan:
Session 1: Psychoeducation I • Addressing Gambling Disorder from a bio-psycho-social perspective.
Materials:
Operant learning model of Gambling Disorder, progressive model of stigma, progressive model of self-stigma, bio-psycho-social CBT model.
Session 2: Psychoeducation II
Materials:
Emotion-thought-behavior connection, thought and emotion analysis, evidence vs. counter-evidence examples and practice, thought-emotion reevaluation.
Session 3: Psychoeducation III • Aligning behaviors with personal values.
Materials:
Values model, summary reminder, vicious cycle diagram.
Session 4: Psychoeducation IV • Exploring the interaction between emotions, thoughts, and behaviors. • Increasing awareness of personal life patterns and experiences. • Discussing foresight and preventative strategies.
Materials:
Integrated summary of addiction and self-stigma, example triggering thoughts, relapse prevention form.
Homework Assignments Homework is a technique commonly used in CBT interventions to reinforce therapeutic gains. Its goal is to support participants in internalizing the intervention content by engaging with the material between sessions. These assignments remain with the participant and serve as a summary of their therapeutic journey.
Participants who attended only one, two, or three psychotherapy sessions were not considered to have completed the intervention. Only those who participated in all four sessions were deemed to have completed it.
Treatment as Usual (TAU):
Throughout the SSCBT-GD intervention, all participants in both the experimental and control groups continued to receive TAU from the addiction outpatient clinic. The content and duration of TAU were determined individually by the clinic psychiatrist. TAU primarily consisted of medical treatment and motivational interviewing when necessary.
Post-intervention assessments (t1) were conducted four weeks after the start of the intervention (the date of the first psychotherapy session was considered the start date).
Follow-up assessments (t2) were conducted four weeks after the post-intervention assessments.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Self Stigma Tailored Cognitive Behavioral Therapy for Gambling Disorder (SSCBT) is a novel intervention designed specifically for this study and has not been previously used or named in existing literature. This 4-session protocol can be integrated into any part of GD treatment. Each session was accompanied by materials specifically designed for that session's content, and assignments related to the session's topics were given at the end of each session.
Session 1: Gambling Disorder from a bio-psycho-social perspective, stigma and self-stigma, CBT introduction, cognitive-behavioral model of self-stigmatization, impact of emotions and cognitive distortions.
S. 2: Self-stigmatizing thoughts and behaviors, identifying automatic thoughts with cognitive techniques, cognitive awareness, and restructuring with evidence examination.
S. 3: Aligning behaviors with values, cognitive restructuring, behavior change, and self-awareness.
S. 4: Prevention strategies, relapse prevention planning.
Other names: SSCBT
All participants continued to receive standard pharmacotherapy from their respective psychiatrists.
All participants continued to receive the standard motivational interviewing intervention for addiction from their psychiatrist.
Time frame: post-treatment (Week 4) and follow-up (Week 8)
Self-stigma will be measured using the Self-Stigma Scale (SSS). Scores range from 36 to 144, with 72 and higher scores indicating severe self-stigmatization. Changes from baseline (Week0) to post-treatment (Week 4) and follow-up (Week 8) will be analyzed.
Time frame: post-treatment (Week 4) and follow-up (Week 8)
Gambling severity will be assessed using the South Oaks Gambling Screen (SOGS). Scores range from 0 to 19, with higher scores indicating greater gambling-related problems. Changes from baseline to post-treatment and follow-up will be analyzed.
Ege University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07661823
ADHD, ADHD - Attention Deficit Disorder With Hyperactivity
Richmond, Virginia, United States
View Trial DetailsNCT06122298
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Bron, France
View Trial DetailsNCT01571752
Activity Space, Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT02337634
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial Details